Breakthrough cancer drug venetoclax approved for use in Australia - National
Publish Date: 10/1/2017
New anti-cancer drug, venetoclax which has the power to ‘melt away’ advanced forms of chronic lymphocytic leukaemia (CLL) was recently granted approval by the Australian Therapeutic Goods Administration (TGA).
Do you have a green thumb? Can you spare a few hours a fortnight to do some gardening for the Leukaemia Foundation? The Leukaemia Foundation is seeking volunteers to help maintain the gardens at our Westmead and Waverton accommodation.
Early clinical data on BGB-3111 encouraging - National
Publish Date: 2/11/2016
Early results from a phase I clinical trial using BGB-3111 – a new treatment for relapsed non-Hodgkin lymphoma (NHL) and chronic lymphocytic leukaemia (CLL) – shows the drug is well tolerated and effective as a single-agent therapy.